United Therapeutics Says FDA Clears IND For The UKidney Xenotransplantation Clinical Trial
United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...
The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors
Dr. Blackman co-founded Day One Biopharmaceuticals in 2018 with a vision to identify, acquire, and develop promising new treatments to address childhood cancers. Under Dr. Blackman’s leadership, Day ...